Jack R Lazar sold $374k of ALAB
director at Astera Labs, Inc.. 2,500 shares at an average of $149.55, traded Nov 20, 2025, filed Nov 21, 2025.
Score components
- +15RoleDirector
- +15Trade size$374k at market
- 0Share of holdings soldSold 2.6% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001277624-25-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -168 | $142.31 | $24k | 97,183 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -461 | $143.60 | $66k | 96,722 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -577 | $145.97 | $84k | 96,145 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -168 | $147.58 | $25k | 95,977 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -219 | $149.17 | $33k | 95,758 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -166 | $152.67 | $25k | 95,592 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -159 | $154.08 | $24k | 95,433 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -286 | $157.85 | $45k | 95,147 | Nov 21, 2025 |
| Nov 20, 2025 | SOpen-market sale Common Stock10b5-1 | -296 | $159.09 | $47k | 94,851 | Nov 21, 2025 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 38Weak | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $21M 157,500 shares | -3% | |
| 24Weak | Astera Labs, Inc. | Jack R Lazar director | $325k 2,500 shares | -3% | |
| 34Weak | Astera Labs, Inc. | Jack R Lazar director | $898k 7,500 shares | -8% | |
| 35Weak | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $1.2M 10,000 shares | -7% | |
| 62Notable | Astera Labs, Inc. | Michael Truett Tate Chief Financial Officer | $1.5M 12,001 shares | -6% | |
| 65Notable | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $12M 94,971 shares | -6% | |
| 49Moderate | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $600k 4,849 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.